On this episode of Stock Movers:
- Corcept Therapeutic (CORT) shares soar after the pharmaceutical firm said its Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer met its overall survival primary endpoint, showing a 35% reduction in death risk compared to nab-paclitaxel alone.
- Abbott Labs (ABT) shares sink after the medical devices firm forecasted first-quarter earnings that fell short of estimates. The company also reported organic sales for the fourth quarter that missed Wall Street’s estimates.
- Arista Networks (ANET) shares jump. The company has been a beneficiary of AI-related spending, rising more than 370% since the end of 2022. Piper Sandler upgraded the stock earlier this month.

Netflix Sinks on Latest Warner Bros. Takeover Drama, Carvana & Meta Jump
05:46

Netflix Drops, Carvana Climbs, P&G Rises on Assurance US Sales Are Bouncing Back
04:25

Intel Shares Climb; P&G Growth Stalls; Paramount Extends Tender Offer For WBD
04:27